DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAA) Operating income
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAA) annual operating income history from SEC filings — each fiscal year as reported.
-$2.8MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMAA financial trends
DMAA RevenueDMAA Net incomeDMAA Net marginDMAA Gross profitDMAA Gross marginDMAA Operating marginDMAA Operating cash flowDMAA Free cash flowDMAA Capital expendituresDMAA Return on equityDMAA Stock buybacksDMAA Dividends paidDMAA Total assetsDMAA Total liabilitiesDMAA Shareholders’ equityDMAA overview →